UVU-15013-27417

2 vaccinations 1 coded response 1 check-in 1 free-text entry 0 call cases

Sex: Female
Age at first dose: 05-11
ZIP prefix: 969
Registered: 2021-12-29

Relationship: Child or adolescent in my care
Guardian: 6NT-33418-55410
Race: Native Hawaiian or other Pacific Islander
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-11-06
Dose 1 — Pfizer-BioNTech
2021-11-27
Dose 2 — Pfizer-BioNTech
2021-12-29
Registered in v-safe
2022-05-28
Survey response — 6 months, dose 2, dependent
MedDRA: Cough, Nasopharyngitis, Pyrexia, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school

Free text: Just regular cold - slight fever, coughing, congestion

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-11-06	Pfizer-BioNTech	No
2	2021-11-27	Pfizer-BioNTech	No

Free text

Release 11 — 6 months, dose 2, dependent

2022-05-28

Symptoms: Just regular cold - slight fever, coughing, congestion

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	Nasopharyngitis	·	·	✓
SD	Pyrexia	·	·	✓
SD	Respiratory tract congestion	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release